Don't Buy In to the Valeant Stock Hype

There's been a ton of online chatter claiming that Valeant stock has become a screaming bargain. And sure, it sounds like a bottom-feeder's dream come true. Since its Aug. 5 high, Valeant stock has dropped more than 65%. If it regained just 69% of its previous high, it would double. But don't believe the hype. This is a deeply troubled company you should stay well away from. Let me show you why you'll be glad you avoided this company at all costs... Tags: NYSE: VRX , tech investing , Valeant Pharmaceuticals Stock , Valeant stock , Valeant stock price , VRX stock , VRX stock price To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Don't Buy In to the Valeant Stock Hype appeared first on Money Morning - We Make Investing Profitable .